Here are detailed study notes for Chapter 47, "Lower Gastrointestinal Problems,"
focusing on the requested pages and structured using Roman numerals.
Study Notes: Chapter 47 – Lower Gastrointestinal
Problems
I. Inflammatory Bowel Disease (IBD) Overview (pp. 1123–1125)
● Definition: Chronic inflammation of the GI tract characterized by periods of
remission and exacerbation.
● Classification:
1. Ulcerative Colitis (UC): Usually limited to the colon and rectum.
2. Crohn’s Disease: Can involve any segment of the GI tract from mouth to
anus.
● Etiology & Pathophysiology:
○ Autoimmune Reaction: An overactive, inappropriate, or sustained
immune response to environmental/bacterial triggers in genetically
susceptible individuals.
○ Risk Factors: Family history (strongest), white/Ashkenazic Jewish origin,
urban living, and diets high in refined sugar, fats, and omega-6 fatty acids.
○ Protective Factors: High intake of raw fruits, vegetables, and omega-3-
rich foods.
● Comparison of UC vs. Crohn’s:
○ Location: * UC: Starts in rectum, moves continuously up the colon; involves
mucosa only.
■ Crohn’s: "Skip lesions" (healthy tissue between inflamed areas); involves
all layers of the bowel wall (transmural).
○ Clinical Manifestations:
■ UC: Bloody diarrhea (up to 10–20 times/day in severe cases), abdominal
pain, tenesmus.
■ Crohn’s: Diarrhea, cramping pain, weight loss (malabsorption), and
nutritional deficiencies.
○ Complications:
■ Both: Increased risk for colorectal cancer (CRC), C. difficile infection, and
perforation.
■ UC Specific: Toxic megacolon (more common).
■ Crohn’s Specific: Fistulas, anal abscesses, and strictures.
II. IBD Nursing & Interprofessional Care (pp. 1124–1125)
● Diagnostic Studies: * CBC (anemia/WBC), electrolytes (imbalance due to
diarrhea), ESR/C-reactive protein (inflammation markers).
○ Colonoscopy: Gold standard to visualize the entire large intestine and
obtain biopsies.
● Drug Therapy Goals: Induce and maintain remission.
focusing on the requested pages and structured using Roman numerals.
Study Notes: Chapter 47 – Lower Gastrointestinal
Problems
I. Inflammatory Bowel Disease (IBD) Overview (pp. 1123–1125)
● Definition: Chronic inflammation of the GI tract characterized by periods of
remission and exacerbation.
● Classification:
1. Ulcerative Colitis (UC): Usually limited to the colon and rectum.
2. Crohn’s Disease: Can involve any segment of the GI tract from mouth to
anus.
● Etiology & Pathophysiology:
○ Autoimmune Reaction: An overactive, inappropriate, or sustained
immune response to environmental/bacterial triggers in genetically
susceptible individuals.
○ Risk Factors: Family history (strongest), white/Ashkenazic Jewish origin,
urban living, and diets high in refined sugar, fats, and omega-6 fatty acids.
○ Protective Factors: High intake of raw fruits, vegetables, and omega-3-
rich foods.
● Comparison of UC vs. Crohn’s:
○ Location: * UC: Starts in rectum, moves continuously up the colon; involves
mucosa only.
■ Crohn’s: "Skip lesions" (healthy tissue between inflamed areas); involves
all layers of the bowel wall (transmural).
○ Clinical Manifestations:
■ UC: Bloody diarrhea (up to 10–20 times/day in severe cases), abdominal
pain, tenesmus.
■ Crohn’s: Diarrhea, cramping pain, weight loss (malabsorption), and
nutritional deficiencies.
○ Complications:
■ Both: Increased risk for colorectal cancer (CRC), C. difficile infection, and
perforation.
■ UC Specific: Toxic megacolon (more common).
■ Crohn’s Specific: Fistulas, anal abscesses, and strictures.
II. IBD Nursing & Interprofessional Care (pp. 1124–1125)
● Diagnostic Studies: * CBC (anemia/WBC), electrolytes (imbalance due to
diarrhea), ESR/C-reactive protein (inflammation markers).
○ Colonoscopy: Gold standard to visualize the entire large intestine and
obtain biopsies.
● Drug Therapy Goals: Induce and maintain remission.
